Sanofi is creating value in its patientcentric care by thinking about the patient in these types of extraordinary circumstances , devising ways to overcome situations such as war or pandemics .
Part of this is the company delivering drugs to patients ’ homes , alongside a nurse where necessary : “ Sometimes a patient is very far away from the clinical site , so a nurse ' s visit with the medicine allows easier access to the clinical trial .”
This reduces the burden of the trial on the patient , something Sanofi is very proud to facilitate . But it ’ s the supply chain itself that ’ s responsible for making this easier for both the nurse and the patient .
“ By reducing the number of trips back and forth to the hospital , we ’ re supporting healthcare staff and patients . But it is down to the patients to make sure that they are taking their medicine on time .”
If we think about value , we have also to discuss a bit about trial design . “ When you have a clinical trial , you ’ re able to influence the trial design to make sure that you limit the risk of shortage and wastage ,” explains Dourlens , who , in his role , has the job of optimising the capacity in supplying the trial .
sustainabilitymag . com 67